Literature DB >> 18239907

Diabetes therapy by lentiviral hepatic insulin gene expression without transformation of liver.

M Elsner, A Jörns, S Lenzen.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18239907     DOI： 10.1007/s00125-008-0931-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor.

Authors:  G Milazzo; L Sciacca; V Papa; I D Goldfine; R Vigneri
Journal:  Mol Carcinog       Date:  1997-01       Impact factor: 4.784

2.  Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells.

Authors:  K Drejer; V Kruse; U D Larsen; P Hougaard; S Bjørn; S Gammeltoft
Journal:  Diabetes       Date:  1991-11       Impact factor: 9.461

3.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

4.  A transgene coding for a human insulin analog has a mitogenic effect on murine embryonic beta cells.

Authors:  M T Vincent; R J Carroll; R E Hammer; S J Chan; Y Guz; D F Steiner; G Teitelman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

5.  Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Authors:  R Zufferey; T Dull; R J Mandel; A Bukovsky; D Quiroz; L Naldini; D Trono
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin.

Authors:  D J Groskreutz; M X Sliwkowski; C M Gorman
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

7.  Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.

Authors:  B Ren; B A O'Brien; M A Swan; M E Koina; N Nassif; M Q Wei; A M Simpson
Journal:  Diabetologia       Date:  2007-06-28       Impact factor: 10.122
  7 in total
  5 in total

Review 1.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

Review 2.  Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet?

Authors:  Ortwin Naujok; Chris Burns; Peter M Jones; Sigurd Lenzen
Journal:  Mol Ther       Date:  2011-08-09       Impact factor: 11.454

3.  Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes.

Authors:  Fulya Erendor; Yunus Emre Eksi; Elif Ozgecan Sahin; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu
Journal:  Mol Ther       Date:  2020-10-31       Impact factor: 11.454

4.  A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells.

Authors:  Vikash Reebye; Pål Sætrom; Paul J Mintz; John J Rossi; Noriyuki Kasahara; Georgios Nteliopoulos; Joanna Nicholls; Abdelali Haoudi; Myrtle Gordon; Nagy A Habib
Journal:  Mol Ther Nucleic Acids       Date:  2013-06-04       Impact factor: 10.183

Review 5.  Efficacy of insulin targeted gene therapy for type 1 diabetes mellitus: A systematic review and meta-analysis of rodent studies.

Authors:  Moosa Rahimi Ghiasi; Hamed Mohammadi; Michael E Symonds; Seyed Mohammad Bagher Tabei; Ahmad Reza Salehi; Sima Jafarpour; Leila Norouzi Barough; Elnaz Rahimi; Zohreh Amirkhani; Maryam Miraghajani; Rasoul Salehi
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.